9 Meters Biopharma Financial Health
How is 9 Meters Biopharma's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: NMTR's short term assets ($18.5M) exceed its short term liabilities ($12.9M).
Long Term Liabilities: NMTR's short term assets ($18.5M) exceed its long term liabilities ($15.8M).
Debt to Equity History and Analysis
Debt Level: NMTR's net debt to equity ratio (18.8%) is considered satisfactory.
Reducing Debt: NMTR had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NMTR has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NMTR has less than a year of cash runway if free cash flow continues to reduce at historical rates of 30.3% each year